# Arcus Biosciences, Inc. (RCUS) FY2026 Q2 Balance Sheet

- Company: Arcus Biosciences, Inc. (RCUS)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001724521-26-000044
- Page: https://plicit.ai/financials/rcus/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/rcus-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 924,000,000 US dollars
- **Current assets**: 756,000,000 US dollars
- **Non-current assets**: 168,000,000 US dollars
- **Liabilities (calculated)**: 460,000,000 US dollars
- **Current liabilities**: 198,000,000 US dollars
- **Non-current liabilities**: 262,000,000 US dollars
- **Equity**: 464,000,000 US dollars
- **Marketable securities**: 552,000,000 US dollars
- **Cash and cash equivalents**: 150,000,000 US dollars
- **Receivable from collaboration partners**: 36,000,000 US dollars
- **Prepaid expenses and other current assets**: 18,000,000 US dollars
- **Long-term marketable securities**: 73,000,000 US dollars
- **Other noncurrent assets**: 59,000,000 US dollars
- **Property and equipment, net**: 36,000,000 US dollars
- **Other current liabilities**: 145,000,000 US dollars
- **Accounts payable ($12 and $24 to a related party)**: 34,000,000 US dollars
- **Deferred revenue ($11 and $35 to a related party)**: 19,000,000 US dollars
- **Other noncurrent liabilities**: 124,000,000 US dollars
- **Long-term debt**: 101,000,000 US dollars
- **Deferred revenue, noncurrent ($19 and $43 to a related party)**: 37,000,000 US dollars
- **Common stock and additional paid-in capital: $0.0001 par value per share; 400.0 shares authorized; 127.0 shares in 2026 and 125.3 shares in 2025 issued and outstanding**: 2,169,000,000 US dollars
- **Accumulated deficit**: negative 1,704,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,000,000 US dollars
- **Gross equity (calculated)**: 2,169,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.